NNovo Nordisk Read More Novo Nordisk Files Etavopivat Sickle Cell Pill With FDA on 27% Fewer Pain Crises2026-11-13 A lab technician performs quality control tests on capsules of DREPAF, a generic formulation used to treat sickle…
NNovo Nordisk Read More Novo Nordisk’s Buyback and Breakthrough Paint a Complex Picture2026-04-21 Novo Nordisk executes major share buybacks and announces positive Phase 3 results for sickle cell drug etavopivat, pressuring…